← FDA Drug Approvals (Drugs@FDA)

DUTREBIS

NDA · New Drug Application · Sponsor: MERCK SHARP DOHME · Approved 2015-02-06

Drug application

FDA Application #

NDA206510

Application type

New Drug Application

Brand name

DUTREBIS

Generic name

Lamivudine

Active ingredients

LAMIVUDINE; RALTEGRAVIR POTASSIUM

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

MERCK SHARP DOHME

First approval

2015-02-06

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown